Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications

BACKGROUND: Idiopathic Pulmonary Fibrosis is a chronic, progressive interstitial lung disease for which there is no cure. However, lung function decline, hospitalizations, and mortality may be reduced with the use of the antifibrotic medications, nintedanib and pirfenidone. Historical outcomes for h...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Bryan T., Thao, Viengneesee, Dempsey, Timothy M., Sangaralingham, Lindsey R., Payne, Stephanie R., Teague, Taylor T., Moua, Teng, Shah, Nilay D., Limper, Andrew H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286036/
https://www.ncbi.nlm.nih.gov/pubmed/34273943
http://dx.doi.org/10.1186/s12890-021-01607-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286036/
https://www.ncbi.nlm.nih.gov/pubmed/34273943
http://dx.doi.org/10.1186/s12890-021-01607-2

Ejemplares similares